Wilmington, Delaware, United States, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The global vaginitis diagnostics market is projected to flourish at a CAGR of 9.5% from 2022 to 2031. As per the report published by TMR, a valuation of US$ 4.1 billion is anticipated for the market in 2031. As of 2023, the market for vaginitis diagnostics is expected to close at US$ 2.0 billion.
The rising prevalence of vaginitis, including bacterial vaginosis, candidiasis, and trichomoniasis, has led to an increased demand for effective and accurate diagnostic tests. With increasing awareness about women's health and the importance of early diagnosis, more women are seeking medical attention for vaginal discomfort and abnormal discharge, driving the growth of the vaginitis diagnostic market.
Request a Report Sample to Gain Comprehensive Insights @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77295
The increase in healthcare expenditure, particularly in developing regions, has led to improved healthcare infrastructure and diagnostics facilities, promoting the adoption of vaginitis diagnostic tests, and driving market growth. Improved healthcare access and availability of diagnostic facilities have also contributed to market growth.
Increase technological advances and the introduction of new diagnostic methods, such as self-sampling kits and point-of-care tests, are designed to offer patients greater comfort and convenience during the diagnostic process. These patient-friendly approaches have contributed to an increase in vaginitis diagnostics rates.
Key Takeaways from the Market Study
- As of 2022, the vaginitis diagnostics market was valued at US$ 1.8 billion
- By disease type, the bacterial vaginosis/vaginitis segment dominates the market, accumulating a high revenue share during the forecast period
- Based on testing type, the nucleic acid amplification segment accounts for the highest market share
- Based on end-use, the hospital segment is expected to generate high revenue during the forecast period.
Expand Operations in the Future – To Get Requisite Details, Ask For a Custom Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=77295
Vaginitis Diagnostics Market: Key Trends and Opportunistic Frontiers
- The growing sexually transmitted disease across the globe and increased awareness about vaginitis infection, are expected to boost the vaginitis diagnostics market demand.
- The introduction of advanced diagnostic technologies, such as molecular diagnostics, nucleic acid amplification tests (NAATs), and point-of-care testing (POCT) solutions, has improved the accuracy and speed of vaginitis diagnosis. These advancements have further fueled the demand for diagnostic tests.
- Increased research and development activities in the field of women's health and diagnostics have led to the development of novel diagnostic tests and biomarkers for vaginitis. These innovations have driven market growth.
- Supportive government initiatives and healthcare policies aimed at improving women's health and increasing access to healthcare services have facilitated the adoption of vaginitis diagnostic tests.
Vaginitis Diagnostics Market – Regional Analysis
- North America is one of the leading regions in the vaginitis diagnostics market. The region's well-established healthcare infrastructure, high awareness about women's health, and increasing prevalence of vaginitis contributed to the market's growth. Technological advancements in diagnostics and growing investments in healthcare further supported the market's expansion in this region.
- The Asia-Pacific region showed considerable potential for market growth. Factors such as a large population of women, increasing awareness about gynecological health, and improving healthcare infrastructure contributed to the expanding demand for vaginitis diagnostics in this region. Rising disposable income and growing investments in healthcare also played a role in market growth.
Vaginitis Diagnostics Market
The vaginitis diagnostic market is still largely consolidated. Competition is intense, with an additional 25+ vaginitis therapy drug players, medication development, clinical trials, and e-commerce. The leading players in the market are investing in new product development, mergers, and acquisitions to gain a competitive edge. Transparency Market Research has profiled the following players in its global vaginitis diagnostic market report:
- Abbott Laboratories
- Atrida
- Becton, Dickinson and Company
- Cepheid (Danaher Corporation)
- F. Hoffmann-La Roche Ltd.
- Hologic, Inc.
- Laboratory Corporation of America Holdings
- QIAGEN
- Quest Diagnostics Incorporated
- Quidel Corporation
Key Developments in Global Vaginitis Diagnostics Market
- Becton Dickson and company is a leading player in the healthcare industry and has a significant presence in various medical fields, including diagnostics, medical devices, and life sciences. BD developed the BD MAX™ Vaginal Panel, a molecular diagnostic test that runs on the BD MAX™ System. The test allows simultaneous detection of the three most common causes of vaginitis: bacterial vaginosis, candidiasis (yeast infection), and trichomoniasis. The test offers fast and accurate results, aiding healthcare providers in timely treatment decisions.
- Danaher Corporation Company developed Xpert® TV a molecular diagnostic test for the detection of Trichomonas vaginalis (TV) infection, which causes trichomoniasis. The test runs on Cepheid's GeneXpert® System, providing accurate and timely results to facilitate early diagnosis and appropriate treatment.
Elevate Your Business Strategy. Buy this Premium Research Report for Immediate Delivery
Vaginitis Diagnostics Market – Key Segments
Testing Type
- Nucleic Acid Amplification Assays
- DNA Probe
- Clinical Test
Disease Type
- Bacterial Vaginosis/Vaginitis
- Vulvovaginal Candidiasis
- Trichomoniasis
- Others
End-user
- Hospitals
- Specialty Clinics
- Others
Region
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact:
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
